This content is current only at the time of printing. This document was printed on 1 October 2020. A current copy is located at https://apvma.gov.au/node/19461
You are here
Proposed approval of the new active constituent, rabbit haemorrhagic disease virus, 08Q712 strain and registration of the product RHDV K5
This consultation closed on 29 January 2016.
The APVMA is considering an application to approve the new active constituent, Rabbit haemorrhagic disease virus, 08Q712 strain and considering an application for the registration of RHDV K5, containing Rabbit haemorrhagic disease virus, 08Q712 strain. The product is to be registered for the infection of wild European rabbits (Oryctolagus cuniculus) in accordance with directions of the appropriate State or Territory government authority.
We invite comment from 15 December 2015 to 29 January 2016 on whether the application for approval of the active constituent and registration of the product should be granted.
The APVMA is able to consider comments relating to the legislative grounds for approval, including:
- occupational health and safety
- public health
- chemistry and manufacture
- residues in food
- environmental safety
- efficacy and target crop safety
For more information, see APVMA Gazette Notice (pages 30–35) from 15 December 2015 and download the Public Release Summary of the Evaluation of Rabbit Haemorrhagic Disease Virus, 08Q712 strain in the product RHDV K5.
Please send your written submission by email, post or fax to:
Case Management and Administration Unit
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
KINGSTON ACT 2604
Phone: +61 2 6210 4701
Fax: +61 2 6210 4721